Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential
about
Consequences of genomic diversity in Mycobacterium tuberculosisIn silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancerMycobacterial PE/PPE proteins at the host-pathogen interface.Insights into the evolutionary history of tubercle bacilli as disclosed by genetic rearrangements within a PE_PGRS duplicated gene pair.Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene region.Comparative analysis of Mycobacterium tuberculosis pe and ppe genes reveals high sequence variation and an apparent absence of selective constraints.The Mycobacterium tuberculosis PE proteins Rv0285 and Rv1386 modulate innate immunity and mediate bacillary survival in macrophagesMycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.PE11 (Rv1169c) selectively alters fatty acid components of Mycobacterium smegmatis and host cell interleukin-6 level accompanied with cell death.Tuberculosis: from genome to vaccine.Frequent homologous recombination events in Mycobacterium tuberculosis PE/PPE multigene families: potential role in antigenic variability.Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design.Protective vaccine efficacy of the complete form of PPE39 protein from Mycobacterium tuberculosis Beijing/K strain in mice.CodaChrome: a tool for the visualization of proteome conservation across all fully sequenced bacterial genomes.HLA-A*0201-restricted Cytotoxic T-cell Epitopes in Three PE/PPE Family Proteins of Mycobacterium tuberculosis
P2860
Q26851285-5D62C10A-A1DA-488C-A84B-A748D963F247Q28303131-4F27BC2A-9068-4CCC-9697-13138EE3CBD4Q30399629-1F247D9C-4D45-4836-BFDC-732D6CF6E1FCQ30828354-CA6B2D7F-6704-4D78-B29A-5650CA30CCE8Q33505452-59A3A963-5EFA-4906-B52E-381579B1DE8FQ34229760-54C8D934-A22C-4099-A93A-21D5659998CAQ34532157-607C4804-3046-4455-8F61-A405856AC4FCQ35186462-CD50AEC6-183A-4960-ADED-36523A3B17BCQ35768918-747102C2-E293-4887-90CD-132D962F73C6Q36238724-867D4AF3-E483-4DBC-A294-8C26A2262356Q36974587-F0776B64-0F83-4092-8572-5E1A62BDD600Q37309256-E97BD1D3-3179-489C-9AF2-3F7540C7DEF1Q38360635-07F4631E-877D-4901-B713-40A720E46EEFQ40064027-07279C59-A4B2-4F20-9019-16369B77A3B9Q41902946-657953FB-E063-4369-B415-8B8B62EE79B6Q57038652-A60B1DE9-A939-4C0C-A544-456955F27AB7
P2860
Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential
description
im Jahr 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2005
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2005
@uk
name
Defining putative T cell epito ...... culosis with vaccine potential
@en
Defining putative T cell epito ...... culosis with vaccine potential
@nl
type
label
Defining putative T cell epito ...... culosis with vaccine potential
@en
Defining putative T cell epito ...... culosis with vaccine potential
@nl
prefLabel
Defining putative T cell epito ...... culosis with vaccine potential
@en
Defining putative T cell epito ...... culosis with vaccine potential
@nl
P2093
P1433
P1476
Defining putative T cell epito ...... culosis with vaccine potential
@en
P2093
P304
P356
10.1016/J.VACCINE.2004.08.046
P407
P577
2005-01-01T00:00:00Z